Publication | Open Access

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Diabetes ManagementUrologyMedicineDiabetesChronic Kidney DiseaseClinical TrialsType 2Diabetic Kidney DiseasePharmacotherapyPioneer 5Diabetes MellitusPharmacologyNephrologyOral Semaglutide